Category: Oncology

A Transcriptomic Solution Customized for Your Every Need

The flexibility of the NanoString® nCounter® platform has been designed to accommodate a wide range of organisms, molecular targets, and sample inputs. Researchers can request “made-to-order” Custom CodeSets for up to 800 project-specific mRNA targets. In doing so, they can...

/ November 11, 2019

The Era of Spatial Transcriptomics Falls into Place at SITC 2019

It’s that time of year again when Fall is upon us and in full swing: leaves are falling off the trees, Halloween has come and gone, pumpkin spice lattes are on every corner, and thousands of immuno-oncology researchers descend on...

/ November 8, 2019

Meet NanoString Scientists at the AMP 2019 Annual Meeting & Expo

When Elaine Lyon, Ph.D., a scientist on the board of the Association for Molecular Pathology (AMP) was asked why she is involved with AMP, its activities and initiatives, she quoted the famous Captain James T. Kirk from Star Trek and...

/ November 4, 2019

The challenges of profiling miRNA Biomarkers from FFPE and Biofluid Samples

In 1993, Dr. Victor Ambros’ lab discovered a small RNA sequence, Lin-4, that was “essential for the normal temporal control of diverse postembryonic developmental events in C. elegans”. Sequence analysis revealed that the molecule was 22 nucleotides long and didn’t...

/ October 21, 2019

The bench side of organ transplant: Challenges and solutions

“It is infinitely better to transplant a heart than bury it to be devoured by worms,” said Dr. Christiaan Barnard, the father of the heart transplant. It’s hard to disagree with this statement! Organ transplant today is an established treatment...

/ October 7, 2019